Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Keiko Ohtani"'
Genotyping of Single Nucleotide Polymorphisms Based on a Mathematical Model for Two-Dimensional Data
Autor:
Megu Ohtaki, Masaru Ushijima, Masaaki Matsuura, Yoshio Miki, Keiko Ohtani, Minoru Isomura, Kenichi Satoh
Publikováno v:
Japanese Journal of Biometrics. 25:61-67
Classification methods typically applied to the Invader assay include k-means clustering and the normal mixture model for original two-dimensional data or angle data. Combining the normal mixture model and angle data might result in an inproved metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8467af21787b91f9c6dd1a6ab65aca56
https://doi.org/10.5691/jjb.25.61
https://doi.org/10.5691/jjb.25.61
Autor:
Toshinori Kobayashi, Takeshi Nakashima, Kazuhisa Komura, Keiko Ohtani, Mutsuo Inoue, Noboru Nakamura
Publikováno v:
Journal of Japanese Association of Hydrological Sciences. 33:255-267
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b7d3c33ca5fef4e6f178457a21fe3f1e
https://doi.org/10.4145/jahs.33.255
https://doi.org/10.4145/jahs.33.255
Publikováno v:
JAPANESE ORTHOPTIC JOURNAL. 22:43-48
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6db172958b0006424c129efcd78b9c04
https://doi.org/10.4263/jorthoptic.22.43
https://doi.org/10.4263/jorthoptic.22.43
Autor:
Hiroshi Kiriu, Keiko Ohtani, Takuro Wada, Minoru Fujita, Kouzo Kashiwado, Yukio Akagi, Yutaka Hirokawa, Kazuki Kashimoto
Publikováno v:
International journal of radiation oncology, biology, physics. 34(2)
To examine the incidence of mandibular bone complication in patients who underwent radiotherapy for T1 and T2 carcinomas of the oral tongue and to analyze the factors contributing to its occurrence.The clinical records of 148 patients with T1 and T2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5361513518eddca89dd33f2ecb42930
https://pubmed.ncbi.nlm.nih.gov/8567334
https://pubmed.ncbi.nlm.nih.gov/8567334
Autor:
Kouhei Kyo, Yuuta Katayama, Tetsurou Ohti, Taiichi Kyo, Megu Ohtaki, Keiko Ohtani, Takesi Okatani, Mitsuhiro Itagaki, Hideki Asaoku, Ryouta Imanaka, K Iwato
Publikováno v:
Blood. 120:3767-3767
Abstract 3767 Background With the introduction of imatinib (IM) and subsequent TKIs such as nilotinib (NI) and dasatinib (DA), deaths due to progression of chronic myeloid leukemia (CML) have decreased dramatically. In such circumstances, the new occ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed30b4cc992a91eea17c2d942d1c5448
https://doi.org/10.1182/blood.v120.21.3767.3767
https://doi.org/10.1182/blood.v120.21.3767.3767